These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1222074)

  • 1. "Transfer factor" therapy in infectious diseases.
    Scalise G
    Boll Ist Sieroter Milan; 1975; 54(6):502-5. PubMed ID: 1222074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer factor therapy: clinical experience and the role of the E rosette assay.
    Sutherland DC; Wilson JD; Douglas R
    N Z Med J; 1977 Jan; 85(579):3-6. PubMed ID: 319390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new approach to immunotherapy: the transfer factor].
    Di Padova F
    Minerva Med; 1979 May; 70(25):1773-85. PubMed ID: 379697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer factor II: results of therapy.
    Spitler LE; Levin AS; Fudenberg HH
    Birth Defects Orig Artic Ser; 1975; 11(1):449-56. PubMed ID: 1096990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious mononucleosis: immunotherapy with EBV-specific transfer factor?
    Jones JF; Pizza G; DeVinci CD
    J Exp Pathol; 1987; 3(4):399-406. PubMed ID: 2842474
    [No Abstract]   [Full Text] [Related]  

  • 6. [First experience with transfer factor therapy in chronic mucocutaneous candida mycosis].
    Westphal HJ; Kaben U; Schröder I; Jenssen HL; Köhler H; Werner H; Mix E
    Dermatol Monatsschr; 1976 Feb; 162(2):124-8. PubMed ID: 955186
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic experiences with transfer factor in chronic cutaneous cadidiasis treatment].
    Szegedi G; Balogh E; Karmazsin L; Szabolcsi M; Szabó G; Oláh E
    Mykosen; 1976 May; 19(5):133-40. PubMed ID: 967193
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of chronic muco-cutaneous candidiasis].
    Da Cruz Sobral F; Silva Picoto AS
    Med Cutan Ibero Lat Am; 1974; (1):41-7. PubMed ID: 4478208
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study.
    Mobacken H; Hanson LA; Lindholm L; Ljunggren C
    Acta Derm Venereol; 1980; 60(1):51-5. PubMed ID: 6153834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of severe complicated measles with non-specific transfer factor.
    Ferrer-Argote VE; Romero-Cabello R; Hernández-Mendoza L; Arista-Viveros A; Rojo-Medina J; Balseca-Olivera F; Fierro M; Gonzalez-Constandse R
    In Vivo; 1994; 8(4):555-7. PubMed ID: 7893983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunological improvement in a patient with chronic mucocutaneous candidiasis treated with transfer factor.
    Businco L; Aiuti F; Franchi F; Frati C; Cavalieri R; Rezza E
    Allergol Immunopathol (Madr); 1976; 4(5):345-50. PubMed ID: 1087530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic muco-cutaneous candidiasis by lymphocyte transfer factor.
    Jose DG
    Aust N Z J Med; 1975 Aug; 5(4):318-23. PubMed ID: 1058670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results on the safety and efficacy of transfer factor in leprosy.
    Hastings RC; Morales MJ; Shannon EJ; Jacobson RR
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):275. PubMed ID: 945240
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunotherapy of leprosy (2nd report). Study on the therapy by means of injection of transfer factor (author's transl)].
    Okada S; Izumi S; Sugiyama K
    Nihon Rai Gakkai Zasshi; 1980; 49(4):190-6. PubMed ID: 7298544
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunostimulants and infectious diseases].
    Grob PJ; Fontana A
    Ther Umsch; 1982 Sep; 39(9):668-74. PubMed ID: 6184840
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfer factor exerts nonspecific effects?
    Saha K
    Int J Lepr Other Mycobact Dis; 1979 Dec; 47(4):614-5. PubMed ID: 122638
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transfer factor. Properties and possible therapeutic applications (author's transl)].
    Grob PJ; Reymond JF; Häcki MA; Frey-Wettstein M
    MMW Munch Med Wochenschr; 1975 Mar; 117(13):517-24. PubMed ID: 805916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive transfer of immunity in lepromatous leprosy patients by Lawrence's transfer factor.
    Mittal MM; Saha K; Maheswari HB
    J Indian Med Assoc; 1976 May; 66(9):197-9. PubMed ID: 965758
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic mucocutaneous candidiasis. Transfer factor and iron metabolism].
    De Moragas Vińas JM; Noguera Tusquets J; Garcia Calderon P
    Med Cutan Ibero Lat Am; 1974; 2(3):183-92. PubMed ID: 4478874
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical possibilities of the use of the transfer factor].
    Svoboda J
    Vnitr Lek; 1983 Jan; 29(1):76-82. PubMed ID: 6829177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.